Farallon Capital Partners, L.P. 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 09:24 am Purchase |
2024-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 13,262,045 7.900% |
1,931,000 (+17.04%) |
Filing |
| 2025-05-15 09:23 am Purchase |
2024-09-30 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 11,331,045 6.900% |
2,954,820 (+35.28%) |
Filing |
| 2025-05-15 09:22 am Purchase |
2024-04-12 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 8,376,225 5.100% |
1,626,021 (+24.09%) |
Filing |
| 2024-02-12 5:11 pm Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 6,750,204 4.100% |
-12,276 (-0.18%) |
Filing |
| 2023-11-09 5:18 pm Purchase |
2023-10-31 | 13G | Revolution Medicines, Inc. RVMD |
Farallon Capital Partners, L.P. | 6,762,480 6.200% |
6,762,480 (New Position) |
Filing |